BSE Live
Oct 01, 16:01Prev. Close
5422.20
Open Price
5416.20
Bid Price (Qty.)
5200.00 (10)
Offer Price (Qty.)
5481.00 (1)
NSE Live
Oct 01, 15:54Prev. Close
5425.00
Open Price
5392.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Alkem Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | |
Total Share Capital | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | |
Reserves and Surplus | 6,135.40 | 5,415.43 | 4,839.86 | 4,443.73 | 3,668.05 | |
Total Reserves and Surplus | 6,135.40 | 5,415.43 | 4,839.86 | 4,443.73 | 3,668.05 | |
Total Shareholders Funds | 6,160.67 | 5,439.34 | 4,863.77 | 4,467.64 | 3,691.96 | |
Minority Interest | 148.30 | 132.61 | 121.55 | 115.23 | 95.02 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 73.91 | 231.30 | 130.73 | 181.56 | 123.46 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.30 | 1.67 | 0.47 | 1.01 | |
Other Long Term Liabilities | 95.10 | 13.39 | 14.33 | 11.29 | 2.65 | |
Long Term Provisions | 222.98 | 173.72 | 150.27 | 102.17 | 82.96 | |
Total Non-Current Liabilities | 391.99 | 418.71 | 297.00 | 295.49 | 210.08 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 1,503.51 | 671.27 | 761.27 | 472.37 | 464.17 | |
Trade Payables | 954.05 | 962.25 | 960.71 | 741.37 | 580.48 | |
Other Current Liabilities | 593.64 | 430.19 | 537.39 | 351.51 | 388.26 | |
Short Term Provisions | 193.38 | 153.82 | 123.94 | 124.44 | 104.69 | |
Total Current Liabilities | 3,244.58 | 2,217.53 | 2,383.31 | 1,689.69 | 1,537.60 | |
Total Capital And Liabilities | 9,945.54 | 8,208.19 | 7,665.63 | 6,568.05 | 5,534.66 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 2,306.29 | 2,105.62 | 1,873.30 | 1,394.45 | 1,031.03 | |
Intangible Assets | 203.27 | 44.26 | 64.90 | 57.75 | 65.45 | |
Capital Work-In-Progress | 362.97 | 492.96 | 380.97 | 299.26 | 172.42 | |
Fixed Assets | 2,872.53 | 2,642.84 | 2,319.17 | 1,751.46 | 1,268.90 | |
Non-Current Investments | 91.50 | 95.74 | 196.47 | 259.44 | 234.39 | |
Deferred Tax Assets [Net] | 932.57 | 707.63 | 655.61 | 696.27 | 516.23 | |
Long Term Loans And Advances | 10.61 | 13.63 | 22.22 | 21.50 | 8.72 | |
Other Non-Current Assets | 134.23 | 151.66 | 211.57 | 577.40 | 384.66 | |
Total Non-Current Assets | 4,439.89 | 3,992.06 | 3,750.44 | 3,650.91 | 2,765.96 | |
CURRENT ASSETS | ||||||
Current Investments | 169.89 | 227.88 | 247.80 | 293.56 | 274.18 | |
Inventories | 1,818.82 | 1,499.87 | 1,442.19 | 1,206.00 | 909.37 | |
Trade Receivables | 1,649.36 | 1,248.41 | 1,080.50 | 713.64 | 567.51 | |
Cash And Cash Equivalents | 1,092.21 | 661.60 | 576.78 | 399.26 | 780.90 | |
Short Term Loans And Advances | 27.97 | 30.80 | 37.92 | 27.95 | 9.85 | |
OtherCurrentAssets | 747.40 | 547.57 | 530.00 | 276.73 | 226.89 | |
Total Current Assets | 5,505.65 | 4,216.13 | 3,915.19 | 2,917.14 | 2,768.70 | |
Total Assets | 9,945.54 | 8,208.19 | 7,665.63 | 6,568.05 | 5,534.66 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 357.59 | 436.60 | 464.73 | 488.58 | 0.00 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 11.96 | 11.96 | 11.96 | 11.96 | 11.96 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 153.04 | 228.22 | 204.34 | |
Non-Current Investments Unquoted Book Value | 36.74 | 40.76 | 43.44 | 31.23 | 30.05 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 0.00 | 0.00 | 22.40 | 17.15 | 1.27 | |
Current Investments Unquoted Book Value | 152.50 | 187.12 | 225.40 | 276.42 | 274.18 |
29.09.2025
23.09.2025
19.09.2025
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.06.2025
Alkem Lab Standalone March 2025 Net Sales at Rs 2,044.94 crore, down 13.55% Y-o-Y
05.06.2025
Alkem Lab Consolidated March 2025 Net Sales at Rs 3,143.75 crore, up 7.08% Y-o-Y
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key